Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Pre-IPOs
Unlock full access to global stock IPOs
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
Masimo Corp Stock Faces Uncertainty Amid Analyst Downgrade and Pending Danaher Acquisition Deal
Masimo Corp’s shares are trading near 52-week highs amidst an anticipated acquisition by Danaher Corporation, despite a recent analyst downgrade from Raymond James to “market perform.” The downgrade reflects the belief that much of the acquisition premium is already factored into the stock price, with the deal expected to close in Q2 or Q3 2026. The medical technology company, known for its noninvasive patient monitoring solutions, presents a strategic opportunity for Danaher, but investors are weighing deal risks, regulatory hurdles, and integration challenges.